We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
+1.79%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$204M
AUM Growth
-$36.1M
(-15%)
Cap. Flow
-$37.5M
Cap. Flow
% of AUM
-18.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
2
Top Buys
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
+$7.5M |
Top Sells
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
+$38.9M |
| 2 |
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
|
+$6.08M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Entrada Therapeutics
TRDA
$267M
| $67M | 32.86% |
4,425,784
| – | – |
|
2
Dyne Therapeutics
DYN
$3.76B
| $55.7M | 27.32% |
4,951,303
| – | – |
|
|
ITOS
3
DELISTED
iTeos Therapeutics
ITOS
| $36.3M | 17.78% |
2,738,785
| – | – |
|
|
RPTX
4
DELISTED
Repare Therapeutics
RPTX
| $23.7M | 11.64% |
2,242,636
| – | – |
|
5
Werewolf Therapeutics
HOWL
$17.9M
| $13.1M | 6.41% |
4,284,172
| – | – |
|
|
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
| $5.82M | 2.85% |
+6,287,101
| New | +$7.5M |
|
|
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $2.22M | 1.09% |
313,139
| – | – |
|
|
ONCR
8
DELISTED
Oncorus, Inc.
ONCR
| $115K | 0.06% |
2,849,464
| – | – |
|
|
TCRR
9
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| – | – |
-4,050,865
| Closed | -$6.08M |
|
|
AMYT
10
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| – | – |
-2,668,843
| Closed | -$38.9M |
|
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM